UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 671

Sortiert nach

P4.11: Galectin-3 is A Potential Mediator of Aldosterone Effects in Vascular Remodeling

Artery research, 2011, Vol.5 (4), p.162-162

2011

Volltextzugriff (PDF)

3.3 Cardiotrophin-1 is a Determinant of Arterial Stiffness and Thickness in Rodents

Artery research, 2010-12, Vol.4 (4), p.147-147

2010

Volltextzugriff (PDF)

Galectin-3 inhibition prevents adipose tissue remodelling in obesity

International Journal of Obesity, 2016-06, Vol.40 (6), p.1034-1038

2016

Volltextzugriff (PDF)

The potential role of leptin in the vascular remodeling associated with obesity

International Journal of Obesity, 2014-12, Vol.38 (12), p.1565-1572

2014

Volltextzugriff (PDF)

P1.52 Regulation and Actions of Cardiotrophin-1 in Cultured Rat Vascular Smooth Muscle Cells

Artery research, 2008, Vol.2 (3), p.104-104

2008

Volltextzugriff (PDF)

Regulation of neutrophil gelatinase-associated lipocalin in aortic valve stenosis

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Histological and molecular characterization of human aortic stenosis: a matter of sex

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

New insights into the pathophysiology of mitral valve disease: molecular characterisation and comparison of the different aetiologic subtypes

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Presence of adipose tissue in aortic valves from aortic regurgitation patients: pathophysiological role and clinical implications

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Galectin-3 is a potential mediator of aldosterone effects in vascular remodeling

Artery research, 2011, Vol.5 (4), p.162-162

2011

Volltextzugriff (PDF)

Cardiotrophin-1 is a determinant of arterial stiffness and thickness in rodents

Artery research, 2010-12, Vol.4 (4), p.147-147

2010

Volltextzugriff (PDF)

P5123Aldosterone effects in mitral valve cells could contribute to the development of mitral valve prolapse

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

P143Mechanisms involved in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity

Cardiovascular research, 2018-04, Vol.114 (suppl_1), p.S37-S37

2018

Volltextzugriff (PDF)

P1421The role of late gadolinium enhancement in left ventricular mass regression and volume reduction following aortic valve replacement for severe aortic stenosis

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Galectin-3 as a novel biotarget in cardiovascular alterations associated to development of severe aortic stenosis

Anales del sistema sanitario de Navarra, 2019-08, Vol.42 (2), p.199-208

2019

Volltextzugriff (PDF)

Specific Activation of the Alternative Cardiac Promoter of Cacna1c by the Mineralocorticoid Receptor

Circulation research, 2018-03, Vol.122 (7), p.e49-e61

2018

Volltextzugriff (PDF)

Regulation and actions of cardiotrophin-1 in cultured rat vascular smooth muscle cells

Artery research, 2008-08, Vol.2 (3), p.104-104

2008

Volltextzugriff (PDF)

P484The inhibition of lysyl oxidase improves the cardiovascular remodeling associated with obesity in rats

Cardiovascular research, 2014-07, Vol.103 (suppl 1), p.S88-S88

2014

Volltextzugriff (PDF)

142 - Role of ngal in the cardiac remodeling associated with myocardial infarction

Archives of Cardiovascular Diseases Supplements, 2017-04, Vol.9 (2), p.206-207

2017

Volltextzugriff (PDF)

CARDIOTROPHIN-1 IS A NEW KEY PLAYER IN CARDIAC AND VASCULAR FIBROSIS AND IN CARDIOVASCULAR DYSFUNCTION BEYOND HYPERTENSION: 3D.03

Journal of hypertension, 2011-06, Vol.29, p.e45

2011

Volltextzugriff (PDF)

CARDIOTROPHIN-1 IS A DETERMINANT OF ARTERIAL STIFFNESS AND THICKNESS IN RODENTS: 3A.03

Journal of hypertension, 2010-06, Vol.28, p.e29-e30

2010

Volltextzugriff (PDF)

A ROLE FOR CARDIOTROPHIN-1 IN MYOCARDIAL FIBROSIS AND LEFT VENTRICULAR DYSFUNCTION: PP.22.346

Journal of hypertension, 2010-06, Vol.28, p.e351

2010

Volltextzugriff (PDF)

A case of Alice-in-Wonderland syndrome probably associated with the use of montelukast

Anales de pediatría (Barcelona, Spain : 2003), 2013-02, Vol.78 (2), p.127

2013

Volltextzugriff (PDF)

Un caso de síndrome de Alicia en el país de las maravillas en probable relación con el uso de montelukast

Anales de pediatría (Barcelona, Spain : 2003), 2013-02, Vol.78 (2), p.127-128

2013

Volltextzugriff (PDF)

6.4: Cardiotrophin-1 Induces Structural and Mechanical Changes in Aorta

Artery research, 2011, Vol.5 (4), p.145-145

2011

Volltextzugriff (PDF)

1 – 25 von 671

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(599)
Mit Volltextzugriff
(601)

Publikationsform

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

P4.11: Galectin-3 is A Potential Mediator of Aldosterone Effects in Vascular Remodeling

3.3 Cardiotrophin-1 is a Determinant of Arterial Stiffness and Thickness in Rodents

Galectin-3 inhibition prevents adipose tissue remodelling in obesity

The potential role of leptin in the vascular remodeling associated with obesity

P1.52 Regulation and Actions of Cardiotrophin-1 in Cultured Rat Vascular Smooth Muscle Cells

Regulation of neutrophil gelatinase-associated lipocalin in aortic valve stenosis

Histological and molecular characterization of human aortic stenosis: a matter of sex

New insights into the pathophysiology of mitral valve disease: molecular characterisation and comparison of the different aetiologic subtypes

Presence of adipose tissue in aortic valves from aortic regurgitation patients: pathophysiological role and clinical implications

Galectin-3 is a potential mediator of aldosterone effects in vascular remodeling

Cardiotrophin-1 is a determinant of arterial stiffness and thickness in rodents

P5123Aldosterone effects in mitral valve cells could contribute to the development of mitral valve prolapse

P143Mechanisms involved in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity

P1421The role of late gadolinium enhancement in left ventricular mass regression and volume reduction following aortic valve replacement for severe aortic stenosis

Galectin-3 as a novel biotarget in cardiovascular alterations associated to development of severe aortic stenosis

Specific Activation of the Alternative Cardiac Promoter of Cacna1c by the Mineralocorticoid Receptor

Regulation and actions of cardiotrophin-1 in cultured rat vascular smooth muscle cells

P484The inhibition of lysyl oxidase improves the cardiovascular remodeling associated with obesity in rats

142 - Role of ngal in the cardiac remodeling associated with myocardial infarction

CARDIOTROPHIN-1 IS A NEW KEY PLAYER IN CARDIAC AND VASCULAR FIBROSIS AND IN CARDIOVASCULAR DYSFUNCTION BEYOND HYPERTENSION: 3D.03

CARDIOTROPHIN-1 IS A DETERMINANT OF ARTERIAL STIFFNESS AND THICKNESS IN RODENTS: 3A.03

A ROLE FOR CARDIOTROPHIN-1 IN MYOCARDIAL FIBROSIS AND LEFT VENTRICULAR DYSFUNCTION: PP.22.346

A case of Alice-in-Wonderland syndrome probably associated with the use of montelukast

Un caso de síndrome de Alicia en el país de las maravillas en probable relación con el uso de montelukast

6.4: Cardiotrophin-1 Induces Structural and Mechanical Changes in Aorta

Suchergebnisse filtern